Skip to content

Covid-19 Vaccine Research Featured in Upcoming August 14 Issue of EIR

The Aug. 14 issue of EIR, scheduled to be delivered to subscribers on Aug. 12, features a review of the explosion of medical advances that have come out of the Covid-19 research and related science. President Donald Trump’s Operation Warp Speed is propelling this massive effort, providing over $10 billion to pharmaceutical companies in the U.S. and Europe. Americans continue to hold strong with the idea of progress when it comes to medical advances. This, despite widespread confusion regarding nuclear energy, the carbon footprint, or the need for space exploration, due to the Malthusian Green New Deal pushed by the British oligarchy. The current central feature of this Green New Deal is to oust Trump, who had the gall to pull the U.S. out of the carbon footprint treaty nonsense.

The EIR coverage, written by Ned Rosinsky, MD, reviews the long history of vaccine development, which has accelerated at an exponential rate up to the present time. This exponential growth has currently reached the point of a Riemannian singularity, in which the advanced use of DNA and RNA techniques developed for vaccine research and production have been generalized to provide treatments for other diseases that have a genetic basis, including common diseases such as cancer, and rarer diseases such as ALS.

This post is for paying subscribers only

Subscribe

Already have an account? Sign In